Amneal Pharmaceuticals received FDA approval for its albuterol sulfate inhalation aerosol on September 19, 2019 [1]. This approval marked the launch of their generic version of ProAir HFA [1].
When can other companies launch generic albuterol sulfate inhalation aerosol?
The patent landscape for albuterol sulfate inhalation aerosol products is complex, with various patents covering different aspects of the drug and its delivery device. According to DrugPatentWatch.com, the exclusivity for the innovator product, ProAir HFA, has been subject to legal challenges and expiring patent claims [2]. The exact date when other generic manufacturers can enter the market depends on the resolution of any ongoing patent litigation and the specific patent expiration dates applicable to Amneal's product and its branded counterpart.
What is albuterol sulfate inhalation aerosol used for?
Albuterol sulfate inhalation aerosol is a short-acting beta-agonist bronchodilator. It is used to treat or prevent bronchospasm in adults and children aged 4 years and older who have mild to moderate asthma [1]. It works by relaxing the muscles in the airways, which helps to open them up, making it easier to breathe [1].
What are the potential side effects of albuterol sulfate inhalation aerosol?
Common side effects reported for albuterol sulfate inhalation aerosol include nervousness, shakiness, dizziness, headache, throat irritation, and coughing [1]. More serious side effects can include paradoxical bronchospasm, where breathing suddenly gets worse after use, and allergic reactions [1].
How does Amneal's albuterol sulfate inhalation aerosol compare to other generics?
Amneal's albuterol sulfate inhalation aerosol is a generic equivalent to the branded ProAir HFA and other generic versions. Generic drugs are required to have the same active ingredient, dosage form, strength, and route of administration, and are generally bioequivalent to their branded counterparts. This means they are expected to have the same clinical effect and safety profile [1].